Aspects of material selection and innovative concepts of car construction using aluminium as best suited light-weight materials were presented, and recent development in established and advanced use of aluminium in passenger cars was discussed that help to meet economic and environmental requirements.
Although a vaccine targeting this virus is available and very effective at preventing cervical cancer, it does not work once cancer is already established, and advanced cervical cancer is very difficult to treat.
Diabetic nephropathy stages: absence, incipient, established, and advanced nephropathy.
We limited our analyses to studies investigating established and advanced diabetic nephropathy.
Page and Schroeder divided the progression of gingival/periodontal lesion into four phases: initial, early, established, and advanced based on clinical and histological findings [ 12].
The UK and New Zealand Internet sites were selected because they have well established and advanced developments in education and career pathways for practice nurses.
This means that they could exert a beneficial major role preventing the development of cancer, but scarcely or negatively affect the progression of established and advanced cancer lesions.
In the present investigation in people with type 1 diabetes, a positive history of LEA was associated with the prevalence of established and advanced diabetic nephropathy, ESRD, myocardial infarction and stroke at baseline.
Some of these statements have potentially significant ramifications in terms of their effect on the ways in which relationships are established and advanced in healthcare now and into the future.
Autoantibody targeting of citrullinated antigens in established and advanced, but not acute, disease suggests that as previously hypothesised inflammation of target tissues could result in the aberrant citrullination of multiple proteins, thereby generating neoantigens that provoke autoreactive B cell responses.
Regression analyses confirmed the associations of a positive history of LEA at baseline with the prevalence of established and advanced diabetic nephropathy at baseline: OR 4.50, 95%% CI 2.33 8.91, p < 0.0001 and OR 5.50, 95%% CI 2.89 10.78, p < 0.0001, respectively, in a model with minimal covariate adjustment (model 1: sex, age, and cohort membership).
